Tonix Pharmaceuticals Holding Corp. Common Stock (TNXP)

About TNXP

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatm…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

142

Website

www.tonixpharma.com/

Fundamentals

1-day range

$13.3$13.98

Market cap

$170.01M

P/E (trailing)

—

P/E (forward)

-1.73

EPS (trailing)

$-14.34

Dividend yield

—

Beta

1.79

Avg. volume

532.7K

Dividend pay date

November 1, 2019

Forecasts

5 analyst ratings

Tonix Pharmaceuticals Holding Corp. Common Stock Competitors

Chosen by industry and closest market cap.

• TNXP

  Tonix Pharmaceuticals Holding Corp. Common Stock

  $13.59

  ▲ 0.18%
  Market cap $170.01MP/E —
  $9.4$34.04
• ARCT

  Arcturus Therapeutics Holdings Inc. Common Stock

  $15.19

  ▼ 6.06%
  Market cap $170.54MP/E —
  $5.5$24.17
• EVO

  Evotec SE American Depositary Shares

  $1.91

  ▼ 2.80%
  Market cap $172.06MP/E —
  $3.18$7.3
• LFCR

  Lifecore Biomedical Inc. Common Stock

  $4.58

  ▲ 0.88%
  Market cap $164.67MP/E —
  $3.63$8.98
• OKUR

  OnKure Therapeutics Inc. Class A Common Stock

  $3.78

  ▼ 1.31%
  Market cap $162.39MP/E —
  $2.23$5.38
• AARD

  Aardvark Therapeutics Inc. Common Stock

  $5.71

  ▼ 13.75%
  Market cap $154.94MP/E —
  $3.35$17.94
• KRRO

  Korro Bio Inc. Common Stock

  $12.94

  ▼ 2.41%
  Market cap $154.90MP/E —
  $5.2$55.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline
  Yahoo · 8/18/2026
• Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript
  Yahoo · 8/17/2026
• Tonix Pharmaceuticals Holding Corp. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/14/2026
• Tonix Delivers A Beat, But The Real Test Starts Now
  SeekingAlpha · 8/11/2026
• Tonix Pharmaceuticals Holding Corp (TNXP) (Q2 2026) Earnings Call Highlights: TONMYA Surges ...
  Yahoo · 8/10/2026
• Tonix Pharmaceuticals Q2 Earnings Call Highlights
  Yahoo · 8/10/2026
• Tonix Pharmaceuticals Holding Corp. (TNXP) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/10/2026
• Tonix Pharmaceuticals Q2 EPS $(2.44) Beats $(2.64) Estimate, Sales $13.544M Beat $7.723M Estimate
  Benzinga · 8/10/2026

• Bradley Saenger · June 30, 2026 · J

  1.5K @ $10.91
• Carolyn E. Taylor · June 12, 2026 · Buy

  1.4K @ $10.55
• Seth Lederman · June 9, 2026 · Buy

  5.0K @ $11.79
• Richard Newcomb Stillwell · June 8, 2026 · Buy

  5.0K @ $11.65
• Richard Newcomb Stillwell · May 12, 2026 · Grant

  22.7K
• Margaret Smith Bell · May 12, 2026 · Grant

  22.7K
• Hunter James Randolph Jr · May 12, 2026 · Grant

  22.7K
• James Treco · May 12, 2026 · Grant

  22.7K
• Carolyn E. Taylor · May 12, 2026 · Grant

  22.7K
• Richard H. Bagger · May 12, 2026 · Grant

  22.7K
• GRANGE DAVID L · May 12, 2026 · Grant

  22.7K
• Adeoye Y. Olukotun · May 12, 2026 · Grant

  22.7K
• Seth Lederman · March 31, 2026 · Buy

  5.0K @ $12.62
• Seth Lederman · March 18, 2026 · Buy

  15.0K @ $14.89

Institutional Ownership

March 31, 2026

Total shares held

4.97M

Total value held

$68.14M

Institutional holders

78